North East and North Cumbria
ICS Formulary
2 Cardiovascular system
02-08 Anticoagulants and protamine
Defibrotide
Formulary
Approved for use in severe veno-occlusive disease following stem cell transplant - in accordance with NHS England commissioning policy.
Use of defibrotide in severe venoocclusive disease following stem cell transplant
Idarucizumab
Formulary
Approved for use as a rapid reversal agent for dabigatran.
Links
Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
County Durham and Darlington DVT Pathway Information
County Durham and Tees Valley Prescribing Guideline for the Use of Anticoagulants in Non-Valvular Atrial Fibrillation
NICE NG148: Acute kidney injury: prevention, detection and management
NICE NG191: COVID-19 rapid guideline: managing COVID-19
North Cumbria - Anticoagulation Decision Support Tool
North Cumbria - Cardiovascular workplan 2022
North Cumbria anticoagulation guideline (2022)
South Tees Hospitals Cardiology drug prescribing guidelines & formulary
Use of defibrotide in severe venoocclusive disease following stem cell transplant
Key
Full Site